Ganoderma lucidum and its pharmaceutically
- 格式:pdf
- 大小:259.64 KB
- 文档页数:37
gait 步态galactagogue 催乳药galactocele 乳腺囊肿galactogogue 催乳药galactoma 乳腺囊肿galactophore 乳管galactophoritis 乳管炎galactopoiesis 乳生成galactopyra 生乳热galactorrhea 乳溢galactoschesis 乳液分泌抑制galactose tolerance test 半乳糖耐量试验galactosemia 半乳糖血galactosis 乳液生成galactostasia 乳液分泌抑制galactostasis 乳液分泌抑制galactostsia 乳液分泌抑制galactosuria 半乳糖尿galea 帽状腱膜galenical 盖仑制剂gall 胆汁gall bladder 胆囊gall bladder meridian 足少阳胆经gall stone 胆石gallop 奔马律gallop rhythm 奔马律gallop sound 奔马律音gallstone 胆石gallstone colic 胆石绞痛gallstone ileus 胆石性肠梗阻galvanic current 伽伐尼电流galvanization 直羚疗法galvanocautery 羚烙法galvanocontractility 电琳缩性galvanofaradization 电感应疗法galvanometer 电疗galvanotherapeutics 直羚疗法galvanotherapy 直羚疗法gamete 配子gametoblast 半月状抱子体gametocide 杀配子剂gametocyte 配子体gametogenesis 配子形成gametogonia 配子生殖gametophagia 配子消失gamic 性的gamma camera 伽马描绘器射线照相机gamma ray unit 射线治疗器gamma rays 线gammaencephalography 射线脑造影术gammagram 线谱gammagraphy 线谱法gamomania 求婚狂gamophobia 结婚恐怖gangliectomy 神经节切除术gangliitis 神经节炎ganglioma 神经节瘤ganglion 神经节ganglion cell 神经节细胞ganglioneuroblastoma 成神经节细胞瘤ganglioneuroma 神经节瘤ganglionic blocker 神经节阻断剂ganglionic stimulant 神经节兴奋剂ganglioplegic 神经节阻断剂gangrene 坏疽gangrenous balanitis 坏疽性龟头炎gangrenous stomatitis 坏疽性口炎gargle 漱口剂gargoylism 脂肪软骨营养不良garrot 止血带gas 瓦斯gas abscess 气脓肿gas chromatography 气体色谱法gas embolism 气体栓塞gas gangrene 气性坏疽gas gangrene bacilli 气性坏疽菌gasping 呼吸运动失调gasser's ganglion 加塞神经节gasserectomy 加塞神经节切除术gastradenitis 胃腺炎gastralgia 胃痛gastratrophia 胃萎缩gastratrophy 胃萎缩gastrectasia 胃扩张gastrectasis 胃扩张gastrectomy 胃切除术gastric atony 胃弛缓gastric biopsy 胃活组织检查gastric cancer 胃癌gastric colic 胃绞痛gastric crisis 胃危象gastric digestion 胃消化gastric dilatation 胃扩张gastric fistula 胃瘘gastric fold 胃襞gastric gland 胃腺gastric indigestion 胃消化不良gastric intubation 胃内插管gastric juice 胃液gastric lavage 洗胃gastric pit 胃小凹gastric secretion 胃液分泌gastric softening 胃软化gastric ulcer 胃溃疡gastritis 胃炎gastroanastomosis 胃胃吻合术gastroatonia 胃弛缓gastroblennorrhea 胃粘液溢gastrocamera 胃内照相机gastrocardiac syndrome 胃心综合征gastrocele 胃膨出gastrocolostomy 胃结肠吻合术gastrocolpotomy 腹式阴道切开术gastrodialysis 胃膜断离gastrodiaphanoscopy 胃透照镜检查gastrodiaphany 胃透照镜检查gastroduodenoscopy 胃十二指肠镜检查gastrodynia 胃痛gastroelytrotomy 腹式阴道切开术gastroenteritis 胃肠炎gastroenteroanastomosis 胃肠吻合术gastroenterologist 胃肠病学家gastroenterology 胃肠病学gastroenteropathy 胃肠病gastroenteroptosis 胃肠下垂gastroesophagostomy 胃食管吻合术gastrogenic diarrhea 胃性腹泻gastrohydrorrhea 胃液溢gastrohysteropexy 腹侧子宫固定术gastrohysterotomy 腹侧子宫切开术gastrojejunostomy 胃空肠吻合术gastrolith 胃石gastrology 胃病学gastrolysis 胃松解术gastromalacia 胃软化gastromegaly 巨胃gastromenia 代偿性胃出血gastropathy 胃病gastrophotor 胃内照相机gastroplasty 胃成形术gastroptosis 胃下垂gastrorrhagia 胃出血gastrorrhaphy 胃缝术gastroscope 胃镜gastroscopy 胃镜检查gastrospasm 胃痉挛gastrostogavage 胃瘘管饲法gastrostomy 胃造口术gastrosurgery 胃外科学gastrotomy 胃切开术gastrotonometer 胃内压测定仪gatism 大小便失禁gaucher's disease 高歇病gauze 薄纱gavage 管饲法gb 1 瞳子gb 10 浮白gb 11 窍阴gb 12 完骨gb 13 本神gb 14 阳白gb 15 临泣gb 16 目窗gb 17 正营gb 18 承灵gb 19 脑空gb 2 听会gb 20 风池gb 21 肩井gb 22 渊腋gb 23 辄筋gb 24 日月gb 25 京门gb 26 带脉gb 27 五枢gb 28 维道gb 29 居gb 3 上关gb 30 环跳gb 31 风市gb 32 中渎gb 33 膝阳关gb 34 阳陵泉gb 35 阳交gb 36 外丘gb 37 光明gb 38 阳辅gb 39 悬钟gb 4 颔厌gb 41 足临泣gb 42 地五会gb 43 侠溪gb 44 窍阴gb 5 悬颅gb 6 悬厘gb 7 曲gb 8 率谷gb 9 天冲gb 足少阳胆经gel 凝胶gelatin 胶gelatin pearl 胶丸gelatinous carcinoma 胶状癌gelatinous tumor 凝胶性瘤gemellology 双胎学gemistocytic cell 原浆性星形细胞gene 基因gene engineering 遗传工程gene frequency 基因频率gene map 基因图gene mutation 基因突变geneogenous 先天性的general anesthesia 全身麻醉general anesthetic 全身麻醉药general circulation 大循环general irradiation 全身照射general surgery 普通外科generalization 全身化generation 世代generative cell 配子genesis 发生genetic 遗传性的genetic code 遗传密吗genetic damage 遗传性损伤genetic death 遗传性死亡genetic disease 遗传性疾病genetic effect 基因效应genetic epidemiology 遗传列病学genetic immunity 遗传免疫genetic information 遗传信息genetic mapping 基因定位图geneticist 遗传学家genetics 遗传学genial 颏的genic environment 遗传环境genicular 膝的genital 生殖的genital gland 性腺genitalia 生殖器genodermatosis 遗传性皮肤病genome 基因组genonema 染色丝genopathy 基因病genotype 基因型genotypic environment 遗传环境genovariation 基因变异genual 膝的genyantrum 上颌骨窦genycheiloplasty 颌唇成形术genyplasty 颌成形术geographic tongue 地图样舌geomedicine 地理医学geopathology 风土病理学geophagia 食土癖geophagy 食土癖gephyrophobia 渡桥恐怖geranium oil 老鹳草油geratic 老年惺gereology 老年医学geriatrician 老年病学家geriatrics 老年病学germ 胚germ cell 胚细胞germ cell tumor 胚组织瘤germ disease 传染病germ hillock 卵丘germ tight filter 除菌滤器germfree animal 无菌动物germicidal lamp 杀菌灯germicide 杀菌剂germinal 胚的germinal cell 原始细胞germinal center 胚中心germinal epithelium 胚上皮germinal layer 胚层germinal membrane 胚盘germinal nucleus 原核germinal rod 孢子小体germinal tumor 胚组织瘤germinoma 胚组织瘤gerodontics 老年牙科学gerodontology 老年牙医学geromorphism 早老现象geront 吉朗特gerontology 老人学gerontophilia 亲老人癖gerontotherapeutics 老年病治疗学gestation 妊娠gestational psychosis 妊娠期精神病gestational toxicosis 妊娠中毒gestosis 妊娠中毒giant cell 巨细胞giant cell carcinoma 巨大细胞癌giant cell granuloma 巨细胞肉芽瘤giant cell hepatitis 巨细胞肝炎giant cell sarcoma 巨细胞肉瘤giant cell tumor 巨细胞瘤giant fetus 巨大胎giant follicular lymphoma 巨滤泡性淋巴瘤giant urticaria 巨大荨麻疹giantism 巨大症gibraltar fever 布鲁菌病giddiness 眩晕gigantism 巨大症gigantosoma 巨人症gill cleft carcinoma 鳃裂癌gingiva 龈gingival bleeding 龈出血gingivectomy 龈切除术gingivitis 龈炎gingivoplasty 龈成形术girdle 齿带girdle pain 束带样痛glabella 眉间glacial acetic acid 冰醋酸gland 腺gland cell 腺细胞glanders 鼻疽glandular cell cancer 腺癌glandular cystitis 腺性膀胱炎glandular epithelium 腺上皮glandular fever 传染性单核细胞增多glandular plague 腺鼠疫glandular stomach 腺胃glaucoma 绿内障glaucosis 青光眼盲gleet 后淋glia 神经胶质glia cell 神经胶质细胞gliacyte 神经胶质细胞glioblastoma 成胶质细胞瘤glioma 神经胶质瘤gliomatosis 神经胶质瘤病gliosis 神经胶质瘤病globulin 球蛋白glomectomy 球切除术glomerulitis 肾小球炎glomerulonephritis 肾小球性肾炎glomerulus 小球glomus 球glomus tumor 血管球瘤glossa 舌glossalgia 舌痛glossectomy 舌切除术glossitis 舌炎glosso palatine arch 舌腭弓glossodynia 舌痛glossolalia 言语不清glossopathy 舌病glossoplasty 舌成形术glossoplegia 舌麻痹glossoptosis 舌下垂glossospasm 舌痉挛glossosteresis 舌切除术glossotomy 舌切开术glottis 声门glucagonoma 细胞瘤glucose 葡糖glucose tolerance test 葡萄糖耐量试验glucoside 葡糖甙glucosuria 糖尿glue 胶剂glutamic acid 谷氨酸gluteal fold 臀沟glutitis 臀肌炎glycemia 糖血glycerine 甘油glycinemia 甘氨酸血glycinuria 甘氨酸尿glycogen 糖原glycogenesis 糖原生成glycogenolysis 糖原分解glycogenosis 糖原贮积病glycolipid 糖脂glycolysis 糖酵解glycoprotein 糖蛋白glycosuria 糖尿gnathalgia 颌痛gnathitis 颌炎gnathology 咀嚼僻gnathoplasty 颌成形术gnathoschisis 颌裂gobelt cell 杯形细胞goblet cell 杯状细胞god's medicine 吗啡goiter 甲状腺肿goiter heart 甲状腺肿心gold therapy 金疗法goldthread root 黄莲golgi apparatus 高尔基体golgi body 高尔基体gonad 性腺gonadectomy 性腺切除术gonadopathy 性腺病gonadotherapy 性激素疗法gonadotropic hormone 促性腺激素gonadotropin 促性腺激素gonagra 膝痛风gonalgia 膝痛gonangiectomy 输精管切除术gonarthritis 膝关节炎gonarthromeningitis 膝关节滑膜炎gonarthrotomy 膝关节切开术gonatagra 膝痛风goniometry 测角术gonioscope 前房角镜gonioscopy 前房角镜检查goniotomy 前房角切开术gonitis 膝关节炎gonoblast 精子胚细胞gonoblennorrhea 淋病性结膜炎gonocyte 生殖母细胞gonorrhea 淋病gonosome 性染色体gonycampsis 膝弯曲gonyocele 膝瘤gonyoncus 膝瘤goose gait 鹅步态gout 痛风governor vessel meridian 督脉经graafian follicle 格拉夫氏滤泡;囊状卵泡grade malignancy 恶性程度gram atom 克原子gram equivalent 克当量gram molecule 克分子gram negative 革兰阴性的gram negative bacilli 革兰阴性杆菌gram positive bacteria 革兰阳性菌gram's staining 革兰染色granular atrophy 颗粒性萎缩granular cast 颗粒圆柱granular cell myoblastoma 颗粒状细胞成肌细胞瘤granular degeneration 颗粒变性granular leukocyte 粒性白细胞granulation 肉芽发生granulation tissue 肉芽组织granule 颗粒granulocyte 粒性白细胞granulocytopenia 粒细胞减少granuloma 肉芽肿granulomatosis 肉芽肿病granulosa cell 粒膜细胞granulosa cell tumor 粒膜细胞瘤graphomania 书写错乱graphorrhea 书写错乱graphospasm 书写痉挛grattage 刷除术gravel 尿砂gravida 孕妇gravidity 妊娠gravitational water 重力水great brain 大脑great omentum 大网膜great toe 趾greater circulation 大循环greater gastric curvature 胃大弯greater pelvis 大骨盆green plants 绿色植物grippe 列性感冒groove 小沟gross anatomy 肉眼病理学gross examination 肉眼检查growth hormone 生长激素gryposis 弯曲guinea pig 豚鼠guinea worm 麦地那龙线虫gullet 食管gulp 吞咽gum bleeding 龈出血gumboil 龈脓肿gumma 梅毒瘤gummatous syphilide 梅毒性屎肿gunshot wound 枪伤gustatory bud 味蕾gustatory cell 味觉细胞gustatory center 味觉中枢gustatory hallucination 味幻觉gustatory organ 味器gustometry 味觉测量法gut 肠guttur 咽gutturotetany 咽痉挛gv 1 长强gv 10 灵台gv 11 神道gv 12 身柱gv 13 陶道gv 14 大椎gv 15 哑门gv 16 风府gv 17 脑户gv 18 强间gv 19 后顶gv 2 腰俞gv 20 百会gv 21 前顶gv 22 囟会gv 23 上星gv 24 神庭gv 25 素gv 26 水沟gv 27 兑端gv 28 龈交gv 3 腰阳关gv 4 命门gv 5 悬枢gv 6 脊中gv 7 中枢gv 8 筋缩gv 9 至阳gv 督脉经gynanatomy 女子解剖学gynandroblastoma 男性细胞瘤gynandroid pelvis 男性样骨盆gynandromorphism 雌雄同体性gynatresia 阴道闭锁gynecoid pelvis 女性骨盆gynecologist 妇科学家gynecology 妇科学gynecomania 求雌狂gynecomastia 男子女性型乳房gynecopathy 妇科病gynecophobia 女性恐怖gynemetrics 妇产科学gynoplastics 女性生殖粕形术gypsum 石膏gyrus 脑回。
美国甘驰
【产品名称】
通用名称:美国甘驰
英文名称:GOUCH!
【成分】樱桃果提取物(10:1浓缩比)、健康肾脏混合配方、白花蛇舌草根提取物、冰草提取物、姜根提取物(含5%姜辣素)等成分
【适应症】
适用于痛风关节炎及痛风引起的持续高尿酸血症、肝肾功能紊乱,手指等末端小关节疼痛、肿胀,踝、肘、膝等大关节红热肿大、刺痛,全身关节痛风石凸出,关节畸形等
【用法用量】
饭前三十分钟服用,每次1~2粒,温水送服
(具体情况不同听从医师指导)
【不良反应】
纯天然生物复合胶囊,无激素化学添加成分,无不良症状
【特殊事项】
如果怀孕,哺乳或服用处方药,谨遵医嘱。
放置在儿童接触不到的地方。
【药理作用】
本品为纯天然提取物,可与其他药物同时服用
【有效期】
3年
【生产企业】
美国原瓶原装进口,美国REDD REMEDIES
【储存方法】
置于阴凉干燥处密封保存,避免阳光直射
不含: 糖、盐、酵母、小麦、麸质、乳制品人造香料、色素或防腐剂、动物成分。
甘氨酸氮甲基转移酶英文回答:Glycine N-methyltransferase (GNMT) is an enzyme that plays a crucial role in the metabolism of glycine. As the name suggests, GNMT is responsible for transferring a methyl group from S-adenosylmethionine (SAM) to the amino group of glycine, resulting in the formation of sarcosine. This methylation reaction is important for maintaining the balance of glycine and SAM in the body.GNMT is primarily found in the liver, where it helps regulate the levels of glycine and SAM. It acts as a key enzyme in the methionine cycle, which is involved in the synthesis and breakdown of various molecules in the body. By controlling the levels of glycine and SAM, GNMT helps maintain the balance between methylation and transmethylation reactions in the liver.The activity of GNMT can be influenced by variousfactors, including genetic variations and environmental factors. For example, certain genetic mutations in the GNMT gene can lead to a decrease in GNMT activity, resulting in elevated levels of glycine and reduced levels of sarcosine. This imbalance has been associated with various diseases, including liver cancer and non-alcoholic fatty liver disease.In addition to its role in glycine metabolism, GNMT has also been implicated in other biological processes. Studies have shown that GNMT can modulate the activity of certain transcription factors, such as nuclear factor kappa B (NF-κB), which are involved in inflammation and immune responses. GNMT has also been shown to interact with other enzymes and proteins, suggesting that it may haveadditional functions beyond its role in glycine metabolism.Overall, GNMT is a key enzyme involved in the metabolism of glycine and plays a crucial role in maintaining the balance of glycine and SAM in the body. Its activity can be influenced by various factors, and alterations in GNMT function have been associated withvarious diseases. Further research is needed to fully understand the complex role of GNMT in human health and disease.中文回答:甘氨酸氮甲基转移酶(GNMT)是一种在甘氨酸代谢中起关键作用的酶。
专利名称:用作腺苷A受体的配体的三唑基-咪唑并吡啶和三唑基嘌呤类的衍生物及其作为药物的应用
专利类型:发明专利
发明人:G·塔齐亚,G·皮埃尔桑蒂,P·米内蒂,M·A·狄瑟塞尔,G·加洛,F·乔吉,L·乔吉
申请号:CN02813848.1
申请日:20020725
公开号:CN1525974A
公开日:
20040901
专利内容由知识产权出版社提供
摘要:本发明公开了通式(I)的化合物,其中的基团如本说明书中所定义,所述的化合物是腺苷A受体拮抗剂且可用作药物,特别用于治疗帕金森病。
申请人:希格马托制药工业公司
地址:意大利罗马
国籍:IT
代理机构:中国国际贸易促进委员会专利商标事务所
代理人:李华英
更多信息请下载全文后查看。
食品科技探究功能性灵芝产品与产业余 贞1,2,陈晗琪1,2,王世龙1,2,周佳丽1,2,张志旭1,2,刘东波1,2*(1.湖南农业大学 园艺学院,湖南长沙 410125;2.国家中医药管理局亚健康干预技术实验室,湖南长沙 410128)摘 要:本文介绍灵芝产品,分析灵芝产品的特征以及灵芝产品及产业的不足,并提出一系列针对性的建议,旨在推动产业的持续健康发展。
关键词:灵芝;产品特征;产业链;标准Explore the Functional Ganoderma Lucidum Products andIndustriesYU Zhen1,2, CHEN Hanqi1,2, WANG Shilong1,2, ZHOU Jiali1,2, ZHANG Zhixu1,2, LIU Dongbo1,2*(1.Hunan Agricultural University of Horticulture, Changsha 410125, China;2.State Key Laboratory of Subhealth Intervention Technology, Changsha 410128, China)Abstract: This paper introduces Ganoderma Lucidum products, analyzes the characteristics of Ganoderma Lucidum products and the shortcomings of Ganoderma Lucidum products and industries, and puts forward a series of targeted suggestions to promote the sustainable and healthy development of the industry.Keywords:Ganoderma Lucidum; product characteristics; industrial chain; standard1 灵芝产品的介绍灵芝是既可入“药”又可为“食”的真菌,且已经过我国有关部门的认定[1]。
阿尔茨海默药物再失败!罗坚强,不哭!导读:医药老伙计们,你们是否还记得去年底阿尔茨海默氏症(AD)领域发生的一件大事?没错,就是罗氏投入巨资研发的一款单抗药物gant医药老伙计们,你们是否还记得去年底阿尔茨海默氏症(AD)领域发生的一件大事?没错,就是罗氏投入巨资研发的一款单抗药物gantenerumab在大型III期临床惨败,这对于罗氏自身乃至AD领域所有研发靶向-淀粉样蛋白的药企而言都是个沉重打击。
此前,业界曾戏言AD就是个大坑,强生、辉瑞、礼来均横尸坑底,所以罗氏的加入也毫不意外。
不过你们可能没想到的是,这家瑞士制药巨头近日再次失足跌落坑底,就连的心都在为罗氏滴血:comeon,罗坚强!这一次,罗氏失败的AD药物是sembragiline,与Evotec公司合作开发。
sembragiline是一种MAO-B抑制剂,这类药物目前用于治疗帕金森,其靶标是单胺氧化酶-B(MAO-B),能够保护多巴胺(dopamine)免于MAO-B的降解。
罗氏目前正在调查sembragiline 用于AD的潜在治疗。
此次公布的一项IIb期临床显示,经过为期一年(52周)的治疗后,sembragiline相比安慰剂未能改善AD患者的认知功能。
去年底,罗氏单抗gantenerumab在大型III期研究(SCarletRoAD)相对安慰剂也未表现出明显疗效迹象,这一结果让gantenerumab项目几近流产。
其实,再往前推半年,罗氏还有一款单抗crenzumab在一项II期临床也失败了。
不过今年3月,百健公布的淀粉样蛋白临床项目的一些早期积极数据,让罗氏看到了一些新的希望,并且考虑将gantenerumab重新推进临床。
百健公布的数据显示,该公司在研单抗药物BIIB037明显逆转了淀粉样蛋白在大脑中的聚集,并且在延缓认知功能减退方面表现出积极迹象。
AD领域新药研发异常艰难,惨淡景象满目皆是,但令人欣慰的是,尽管该领域失败风险极高,但尚无证据表明生物医药行业将要放弃,该领域的诸多失败与挫折确实让许多人失望,但这些不成功的尝试却是至关重要的垫脚石,帮助推动对这种极其复杂疾病的认识,同时调整研究方向并提供新的线索,让科学不断向前迈进。
灵芝作为普通食品原料的应用前景分析王 雷1,李 健2,王 强3(1.六安市市场监管综合行政执法支队,安徽六安 237000;2.六安市中医院,安徽六安 237000;3.安徽康缘药业有限公司,安徽金寨 237300)摘 要:灵芝是一种名贵中药材,同时具有较高的食用价值,我国部分地区已将灵芝作为食品食用。
但目前灵芝不能作为普通食品原料应用于食品加工中,限制了灵芝产业的发展。
本文通过分析政策性文件及借鉴其他食品原料的应用普及经验,提出将灵芝作为普通食品原料的对策,以期为灵芝产业的发展提供参考。
关键词:灵芝;普通食品原料;保健食品原料;问题及对策Analysis of Application Prospect of Ganoderma lucidum asCommon Food Raw MaterialWANG Lei1, LI Jian2, WANG Qiang3(1.Lu’an Market Supervision Comprehensive Administrative Law Enforcement Detachment, Lu’an 237000, China; 2.Lu’an Traditional Chinese Medicine Hospital, Lu’an 237000, China; 3.Anhui KangyuanPharmaceutical Co., Ltd., Jinzhai 237300, China)Abstract:Ganoderma lucidum is a kind of precious traditional Chinese medicine with high edible value. Ganoderma lucidum has been used as food in some areas of China. However, at present, Ganoderma lucidum can not be used as ordinary food raw materials in food processing, which limits the development of Ganoderma lucidum industry. By analyzing the policy documents and learning from the application and popularization experience of other food raw materials, this paper puts forward the countermeasures of using Ganoderma lucidum as ordinary food raw materials, in order to provide reference for the development of Ganoderma lucidum industry.Keywords:Ganoderma lucidum; common food raw materials; health food raw materials; problems and countermeasures1 灵芝简介灵芝(Ganoderma lucidum)属于担子菌门担子菌纲多孔菌科灵芝属药用真菌,具有很高的药用价值,是我国传统的名贵中药材,拥有2 000多年的历史[1-2]。
富马酸贝达喹啉结构式英文回答:Fumarate Bedaquiline.Fumarate bedaquiline is an antitubercular drug that belongs to the diarylquinoline class of antibiotics. It was approved by the United States Food and Drug Administration (FDA) in 2012 for the treatment of multidrug-resistant tuberculosis (MDR-TB) in adults.Chemical Structure.The chemical structure of fumarate bedaquiline is:C40H48F2N4O6。
It is a yellow to orange powder that is freely soluble in DMSO and sparingly soluble in water.Mechanism of Action.Fumarate bedaquiline inhibits the mycobacterial ATP synthase, which is essential for the energy production of the bacteria. This inhibition leads to the accumulation of toxic metabolites in the bacteria, ultimately resulting in cell death.Pharmacokinetics.Fumarate bedaquiline is well absorbed after oral administration, with peak plasma concentrations occurring within 2-4 hours. It is highly bound to plasma proteins (99%) and has a volume of distribution of approximately 1000 L. Fumarate bedaquiline is metabolized by the cytochrome P450 enzymes CYP3A4 and CYP2D6, and it has a half-life of approximately 25 days.Clinical Efficacy.Fumarate bedaquiline has demonstrated efficacy in the treatment of MDR-TB in adults. In a clinical trial,patients who received fumarate bedaquiline in combination with other antitubercular drugs had a higher cure rate than those who received standard treatment alone.Adverse Effects.The most common adverse effects of fumarate bedaquiline include nausea, vomiting, diarrhea, abdominal pain, and headache. Serious adverse effects, such as hepatotoxicity and QT prolongation, have also been reported.Dosage.The recommended dosage of fumarate bedaquiline is 400 mg once daily. It is usually administered for a duration of 6-9 months.Conclusion.Fumarate bedaquiline is an important new drug for the treatment of MDR-TB. It is effective in combination with other antitubercular drugs, and it has a favorable safetyprofile.中文回答:富马酸贝达喹啉。
美国FDA批准Ztalmy口服混悬剂用于治疗CDD相关的癫
痫发作
佚名
【期刊名称】《中国处方药》
【年(卷),期】2022(20)4
【摘要】近日,Marinus Pharma公司宣布美国食品和药物管理局(FDA)已批准Ztalmy(ganaxolone,加奈索酮)口服混悬剂:该药每天服药3次,用于2岁及以上患者,治疗与细胞周期蛋白依赖性激酶样5(CDKL5)缺乏症(CDD)相关的癫痫发作。
这是美国FDA批准的首个用于治疗CDD的药物。
Ztalmy通过优先审查程序获得批准。
此前,美国FDA已授予Ztalmy治疗CDD的孤儿药资格(ODD)和罕见儿科疾病资格(RPDD)。
美国FDA批准Ztalmy治疗CDD相关癫痫发作,基于Ⅲ期Marigold试验的数据。
这是一项双盲安慰剂对照试验,在101例患者中开展。
试验中,Ztalmy治疗组患者在28 d中主要运动性发作频率的中位数减少了30.7%,而安慰剂组患者减少了6.9%,达到了试验的主要终点(P=0.0036)。
【总页数】1页(PI0001)
【正文语种】中文
【中图分类】R74
【相关文献】
1.brivaracetam获FDA批准用于发作性癫痫辅助治疗
2.美国FDA批准XCOPRI(cenobamate)片剂用于治疗癫痫部分性发作
3.美国FDA批准
Briviact(brivaracetam)用于治疗部分性发作型癫痫4.FDA批准依佐加滨用于成人
部分发作性癫痫辅助治疗5.FDA批准Banzei口服混悬剂用于辅助治疗Lennox—Gastaut综合征
因版权原因,仅展示原文概要,查看原文内容请购买。
2020年4月综述灵芝(Ganoderma lucidum )又称为瑞草、神芝、万年蕈等,是一种多孔菌科真菌赤芝或紫芝的干燥子实体。
平味甘,归心、肝、肺、肾经,能安心神、健脾胃、益气血,主治失眠、神疲乏力、心悸、冠心病、肿瘤等[1]。
灵芝含有多种化学成分,其中的活性成分以多糖、三萜、核苷、甾醇类为主,具有一定的抗肿瘤、抗炎、保肝、降糖、抗衰老等活性[2]。
在我国,灵芝作为药用已有2000多年的历史,据《神农本草经》记载,灵芝具有扶正固本、滋补强壮、延年益寿的功效;在《本草纲目》中,灵芝被记录为能够提神和延年益寿。
现代科学研究发现灵芝及灵芝制品具有抗氧化、抗肿瘤、保肝护肝、降血糖、治疗神经衰弱等药理作用,灵芝的药理作用日渐受到关注[3],常以生药材、药用制剂、保健品饮品等面向市场。
本文对近年来灵芝药理作用的研究进展进行总结,并梳理其临床应用现状,为灵芝相关健康产品的开发提供一定的参考与思路。
1防治心血管疾病心血管疾病(CVD )是心脏和血管的疾病,是全世界发病率和死亡率最高的疾病之一。
灵芝可以降低患心血管疾病的风险,预防多种疾病模型的心脏损害[4],对心血管系统主要表现为保护心肌损伤、抗心肌缺血等作用。
Kuok 等[5]使用ISO 诱发小鼠心肌损伤,并在对小鼠进行皮下注射ISO 之前使其口服灵芝子实体乙醇水提液,以此操作的小鼠未出现心肌损伤现象,由此进一步研究发现水提液中有效成分灵芝三萜类化合物GA 可消除注射了ISO 小鼠的心肌梗塞和纤维化,从而得出GA 可预防小鼠的应激性心肌损伤。
左冬冬等[6]通过造模大鼠心肌缺血模型,分组给药观察灵芝多糖(GLP )对心肌缺血大鼠各项指标的影响,发现GLP 使大鼠心肌梗死面积明显缩小,血清CK 、Troponin 含量明显降低,表明灵芝可较好地保护缺血性心肌损伤。
Xie 等[7]研究灵芝DOI :10.19347/ki.2096-1413.202010077基金项目:浙江中医药大学学生发展性资助项目。
药品含量英文写法Possible article:Understanding Drug Dosage: A Guide to Drug ContentAs consumers of medications, it is important to understand the quantities of active and inactive ingredients in the drugs we take. Different dosages can have different effects on our bodies, and improper use can cause harm, either by inadequate treatment or by overexposure to substances. Inthis article, we will explain some key terms related to drug content and offer tips for reading and interpreting labels and instructions.1. Dosage strength: This refers to the amount of active ingredient(s) in a unit dose of the drug, usually measured in milligrams (mg) or micrograms (mcg). The dosage strength can vary depending on the condition being treated, the age and weight of the patient, and other factors. For example, a common dose of aspirin is 325 mg, while a dose of albuterol inhaler for asthma may be 90 mcg per puff.2. Total drug content: This is the sum of the active and inactive ingredients in a drug, measured in grams or milligrams. The total drug content may not always reflect the dosage strength or concentration, as some drugs have lower potencies or require larger volumes for optimal effect. For example, a packet of cough syrup may contain 10 grams of liquid, but only 20 mg of codeine phosphate.3. Concentration: This is the ratio of the amount of active ingredient(s) to the amount of solvent or base in a drug, usually expressed as a percentage or parts per million (ppm). Concentration can affect the taste, stability, and effectiveness of a drug, and may determine the route of administration. For example, a solution of insulin may have a concentration of 100 units per milliliter (U/mL), while a cream containing hydrocortisone may have a concentration of 1%.4. Dosing regimen: This refers to the frequency, duration,and amount of doses that a patient should take over a certain period of time based on the prescribed therapy. The dosing regimen can impact the efficacy and safety of a drug, as well as the patient's adherence and compliance. For example, a person taking antibiotics for a bacterial infection may needto take 500 mg orally twice a day for 7 days, while a person with chronic pain may need to take 10 mg of oxycodone every 4 hours as needed.5. Routes of administration: This is the method by which a drug is delivered into the body, such as oral (by mouth), topical (on the skin), inhalation (through the nose or mouth), injection (into a vein, muscle, or tissue), or rectal (intothe anus). Different routes of administration can affect the speed, duration, and bioavailability of a drug, as well asits side effects and risks. For example, a person with hypertension may take a 10 mg tablet of amlodipine orallyonce a day, while a person with severe pain may receive a 10 mg injection of morphine intravenously every 6 hours.When reading a drug label or instruction, pay attention to the dosage strength, total drug content, concentration, dosing regimen, and route of administration. Consult your healthcare provider or pharmacist if you have any questions or concerns about the drug or its use. Avoid self-medicating or altering your dosing without medical advice, as this can lead to acute or chronic health problems. Be aware of potential interactions between different drugs, supplements, or foods, and report any adverse reactions promptly to your healthcare provider. By understanding drug content, you can make informed decisions about your health and well-being.。
北京曼思特益母草苷结构式
益母草苷:
分子式:C15H24O9
分子量:348.35
储存条件:-20℃,有效期2年,溶入溶剂后-20℃请尽量在一个月内使用
益母草苷是一种化学物质。
纯度98%以上,检测方法HPLC,用于医药研究及含量测定。
益母草苷是一种环烯醚萜苷类化合物,主要来源于地黄、益母草等。
益母草苷具有抗癌、神经保护、抗炎、利尿等功效。
一种预防原发性高血压的药物组合物,包含下列原料按照重量份数配制而成:无羁萜-3β-醇1~100份、黄芪多糖组分a310~100份、连翘苷3~100份,白藜芦醇10~100份和益母草苷a7~100份。
研究发现,无羁萜-3β-醇、黄芪多糖组分a3、连翘苷,白藜芦醇和益母草苷a 组成的复方可以有效降低高血压模型大鼠的收缩压和舒张压,降低血浆血管紧张素ii(angii)水平,升高血浆血管舒张因子一氧化氮(no)水平,增加血管组织一氧化氮合酶(enos)蛋白表达以及基因表达。
益母草苷或其前药的用途,尤其是益母草苷或其前药用于制备降血压的药物的用途。
•基础研究•从灵芝提取的副产物中快速分离灵芝酸国家菌草工程技术研究中心(福州350001) 林冬梅王赛贞*1罗虹建林占焴林树钱【摘要】目的从灵芝水提取生产过程中浓缩罐底部沉淀的浸膏状产物中分离制备灵芝酸。
方法将灵芝水提取生产过程中浓缩罐底部沉淀的浸膏状产物溶于乙醇,超声,高速离心,得到上清液。
采用Flash中压制备,粗分离获得3种样品,再通过p e p高压制备,高效液相检测追踪。
结果依次收集相同部位3种样品,经浓缩重结晶得白色晶体,纯度均达98%以上。
获得3种结晶,分别经气相一质谱、红外光谱、1HNMR、和13CNMR等波谱手段,结合相关文献数据,确定白色结晶分别为灵芝酸C£、B和A.从副产物中提取得率分别为灵芝酸A:1.62%〜3.00%;灵芝酸B:1.83%〜2.59%;灵芝酸C£:1.03%〜1.52%。
结论利用富含灵芝酸的废弃副产物快速分离纯化制备出对照品,可为灵芝酸的药理研究和检测用对照品提供充足的来源。
【关键词】灵芝;灵芝提取副产物;全息快速纯化色谱仪;灵芝酸;结构鉴定【中图分类号】S567. 3+ 1【文献标识码】A【文章编号】1002-2600(2018)03-0135-04Rapid separation of ganoderic acid from the extracted by-products of Ganoderma lucidum L I N D o n g m e i,W A N G Saizhen,LN O H o n g j i a,L I N Z h a n x i,L I N Shuqian.nology ,FuzOou,F u jia n 350001,China【Abstract】Objective TO isolate the ganoderic acids from the cxtract-likc product precipitated from the bottom of the concentration tank during the water extraction and production process of Ganoderma lucidum (G.lucidum).Methods T'he extract-like product precipitated at the bottom of the concentration tank in the productionproccss o fG.lucidum water extractionwas dissolved in ethanol,sonicated,and centrifuged at high speed to obtain a supernatant."Three kinds of crude samples wereobtained by using the preparation of Flash medium pressure,then prepared by Prep high pressure with detection tracking ofHPLC.Results In turn,three samples of the same parts were collected,and white crystals were obtained by concentration and rccrystallization,with the purity of over 98%. T^h ree kinds of crystallization were identified respectively as Ganoderic acid C2,Ganoderic acidB andGanodcric acidAby u singGC-MS,IR, 1HNMR,and 13CNMR and other spectral means,combined withrelevant literature datas.The extraction rates from by-products were ganoderic acid A:1.62% 一3.00%; ganoderic acid B:1.83%—2.59%; Ganoderic acid C2: 1.03 %-1.5 2%. Conclusion The use of rapid separation and purification of waste byproducts rich in ganoderic acid to prepare a reference substance p rovides a sufficient source for pharmacological r of ganoderic acid.【Keywords】Ganoderma lucidum;processing by-products of Ganoderma lucidum;holographic fast purification chromatograph;ganoderic acid;structural identification灵芝[Ganoderm a lucidum(C u rtis:F r.) P.K a s t]是重要的药用真菌。
Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondriamediated apoptosis in lung cancer cellsWen Tang a ,Jian-Wen Liu a,⁎,Wei-Ming Zhao b ,Dong-Zhi Wei a ,Jian-Jiang Zhong a,c,⁎aState Key Laboratory of Bioreactor Engineering,East China University of Science and Technology,130Meilong Road,Shanghai 200237,ChinabDepartment of Natural Products Chemistry,Shanghai Institute of Materia Medica,Shanghai Institutes for Biological Sciences,Chinese Academy of Sciences,Shanghai 201203,ChinacKey Laboratory of Microbial Metabolism,Ministry of Education,College of Life Science &Biotechnology,Shanghai Jiao Tong University,800Dong-Chuan Road,Minhang,Shanghai 200240,ChinaReceived 7June 2006;accepted 4September 2006AbstractGanoderma lucidum is a well-known traditional Chinese medicinal herb containing many bioactive compounds.Ganoderic acid T (GA-T),which is a lanostane triterpenoid purified from methanol extract of G.lucidum mycelia,was found to exert cytotoxicity on various human carcinoma cell lines in a dose-dependent manner,while it was less toxic to normal human cell lines.Animal experiments in vivo also showed that GA-T suppressed the growth of human solid tumor in athymic mice.It markedly inhibited the proliferation of a highly metastatic lung cancer cell line (95-D)by apoptosis induction and cell cycle arrest at G 1phase.Moreover,reduction of mitochondria membrane potential (Δψm )and release of cytochrome c were observed during the induced apoptosis.Our data further indicate that the expression of proteins p53and Bax in 95-D cells was increased in a time-dependent manner,whereas the expression of Bcl-2was not significantly changed;thus the ratio of Bcl-2/Bax was decreased.The results show that the apoptosis induction of GA-T was mediated by mitochondrial dysfunctions.Furthermore,stimulation of the activity of caspase-3but not caspase-8was observed during apoptosis.The experiments using inhibitors of caspases (Z-VAD-FMK,Z-DEVD-FMK and Z-IETD-FMK)confirmed that caspase-3was involved in the apoptosis.All our findings demonstrate that GA-T induced apoptosis of metastatic lung tumor cells through intrinsic pathway related to mitochondrial dysfunction and p53expression,and it may be a potentially useful chemotherapeutic agent.©2006Elsevier Inc.All rights reserved.Keywords:Ganoderma lucidum ;Ganoderic acid;Apoptosis;Caspases;Lung tumor cellsIntroductionGanoderma lucidum (Fr.)Karst (Polyporaceae)is an important traditional Chinese medicinal mushroom used for several thousand years in China,Japan,and other countries.Evidence has accumulated concerning the medicinal application of ganoderma in the treatment of various diseases,such as cancers and immunological disorders,and in recent years the biotechnological utilization of the mushroom has been very popular (Zhong and Tang,2004).It is well documented that the natural mixtures of triterpe-noids in G.lucidum inhibit proliferation of human and mouse carcinoma cell lines (Liu et al.,2002;Sliva,2003,2004).The cytotoxicity of extract of triterpene-enriched Ganoderma tsugae was claimed to be mediated through apoptosis and cell cycle arrest in MCF-7human breast,prostate cancer cells and PC-3cells (Gao and Zhou,2003;Jiang et al.,2004).Other studies have shown that apoptosis induced by triterpene-enriched extracts of G.lucidum was brought about through suppressing protein kinase C,activating mitogen-activated protein kinases and G 2-phase cell cycle arrest (Lin et al.,2003);through indu-cing a marked decrease of intracellular calcium level (Zhu et al.,2000);through inducing NAD(P)H:quinone oxidoreductase in cultured hepalcic7murine hepatoma cells (Ha et al.,2000);by activating MAP kinases in rat pheochromocytoma PC12cells (Cheung et al.,2000)or stimulating actin polymerizationinLife Sciences 80(2006)205–211/locate/lifescie⁎Corresponding authors.Zhong is to be contacted at College of Life Science and Biotechnology,SJTU,800Dong-Chuan Road,Shanghai 200240,China.Tel./fax:+862134204831.Liu,Department of Molecular and Cellular Pharmacology,ECUST,Shanghai 200237,China.E-mail addresses:jjzhong@ (J.-J.Zhong),liujian@ (J.-W.Liu).0024-3205/$-see front matter ©2006Elsevier Inc.All rights reserved.doi:10.1016/j.lfs.2006.09.001bladder cancer cells in vitro(Lu et al.,2004).However,it is difficult to identify whether or not the ingredients in extracts (mixtures)have antagonistic or synergistic biological effects, and it is also unclear what compound in extracts is mainly responsible for the bioactivities,which makes the study of structure–activity relationship difficult.Therefore,the use of a purified triterpene is required to reveal the acting mechanism of responsible compounds and to further screen and rationally design structurally similar lead compounds.Until now,there has been a lack of investigation using purified triterpenes to study bioactivity mechanism except for ganoderic acid X(GA-X)(Li et al.,2005).GA-X was shown to induce apoptosis of cancer cells,and the disruption of mito-chondrial membrane,cytosolic release of cytochrome c and activation of caspase-3under its treatment were also reported(Li et al.,2005).However,whether caspase-8and p53was involved in its induced apoptosis is unclear.In this work,the cytotoxicity of ganoderic acid T(GA-T),a triterpenoid purified from bioreactor-cultivated mycelia of ganoderma by our lab(Fig.1)(Tang,2006),to various human carcinoma cell lines was investigated.Furthermore,the growth inhibitory effect of GA-T on95-D cells and molecular events triggered by GA-T in the apoptosis of95-D cells,including the effects on caspase-8and p53,are elucidated.The work is con-sidered useful to the development of interesting chemothera-peutic drugs.Materials and methodsMaterialsRPMI1640and Dulbecco's Modified Eagle Medium (DMEM),trypsin,MTT,PI were obtained from Sigma Chemical Co.(St Louis,MO).Fetal bovine serum(FBS)and antibiotics (penicillin and streptomycin mixture)were purchased from Huanmei Co.(Shanghai,China).Antibodies for actin and p53, Bax,Bcl-2were purchased from BD Biosciences PharMingen, USA.Goat anti-rabbit IgG-conjugated to horseradish peroxidase (HRP)and goat anti-mouse IgG-conjugated to HRP were pur-chased from Biovision(Mountain View,CA).Selective inhibitors of caspase-3(Z-DEVE-FMK),and caspase-8(Z-IETD-FMK) and general caspase inhibitors(Z-V AD-FMK)were purchased from Biovision(Mountain View,CA).Cytochrome c was pur-chased from Sigma(Germany).GA-T was purified with semi-preparative liquid chromatog-raphy in our lab with its purity over99%(Tang,2006).Stock solutions of GA-T were prepared in dimethyl sulfoxide(DMSO) and stored at−20°C.Further dilutions were made with RPMI 1640medium just before use.The final concentration of DMSO was less than0.1%.Cell culturesHuman highly metastatic lung tumor cell line95-D(lung), human liver tumor cell line SMMC7721(liver),human epidermal cancer KB-A-1and KB-3-1(epidermis),human cervixal cancer HeLa(cervix),and human normal cell line HLF(lung)and L-02 (liver)were purchased from the Center of Cell Culture Collection of Academia Sinica(Shanghai,China).All those cell lines were cultured in RPMI1640medium containing10%heat-inactivated fetal bovine serum,100units/ml penicillin,and100μg/ml streptomycin in an atmosphere of5%CO2and95%air at37°C. Cells(1×105/ml)were treated with GA-T at various indicated concentrations and for various periods.In some experiments, before addition of GA-T to the cultures,cells were pre-incubated for60min at37°C with selective caspase inhibitors,i.e.,caspase-3inhibitor,Z-DEVD-FMK,10μM;caspase-8inhibitor,Z-IETD-FMK,10μM;and pan-caspase inhibitor,Z-V AD-FMK,10μM. Cell proliferation assayThe1×105cells/ml were plated in96-well tissue culture plate, and treated with different concentrations of GA-T(0,6,12.5,25 and50μg/ml)after4h.Cells were incubated for another24h for cell proliferation.Viability of cells was evaluated by MTT[3-(4,5-dimethylthiazo l-2-yl)-2,5-diphenyltetrazolium bromide]reduc-tion method.The cells were stained with MTT for4h and then incubated with lysis buffer(20%SDS in50%N,N-dimethylfor-mamide)for another30min.Optical density at570nm was detected for monitoring the cell viability.Effects of the drugs on inhibition of cell growth were calculated,and the cells treated with DMSO at same concentrations as in the drugs used as controls.For colony formation assay,a total of2000cells was resus-pended in RPMI1640medium containing10%FBS and0.35% agar and plated on plates with a solidified bottom layer(0.5% agar in growth medium).The plates were incubated in a humi-dified incubator at37°C.Various concentrations of GA-T were added to cells,and cells were cultured for12days until colonies appeared.Then,cells were fixed and stained with crystal violet and counted.Dose–response curves and the concentration of GA-T inhibiting colony formation by50%(EC50)were obtained. Cell cycle distribution and apoptosis evaluationCell cycle parameters were analyzed by flow cytometry.After induction treatment under50μg/ml,cells were fixed with ethanol and then stained with propidium iodide after removing the RNA in the cells by RNase treatment,and the fluorescence of individual nuclei(about10,000events)was analyzed by flow cytometry (Becton Dickinson FACScan,USA).The percentage of cells in the G1,S and G2–M phases of the cell cycle was determined.Apoptosis was detected by annexin V-FITC binding assay. Normal,apoptotic,and necrotic cells were distinguishedby Fig.1.Structure of ganoderic acid T(GA-T).206W.Tang et al./Life Sciences80(2006)205–211using the annexin V-propidium iodide(PI)kit according to the manufacturer's instructions(Roche Diagnostics,Germany). After washing in PBS buffer,cells were resuspended for10min in the staining solution and analyzed by flow cytometry.The percentages of viable and dead cells were determined with about 10,000cells/sample.Mitochondrial membrane potential analysis(Δψm)Mitochondrial transmembrane potential was analyzed by flow cytometry.Cells under the GA-T treatment were incubated with 50nM3,3′-dihexyloxacarbocyanine iodide(DiOC6)(Molecular Probes,USA)for15min at37°C,and associated fluorescence alterations in95-D cells were evaluated by FACScan flow cytometry(Becton Dickinson and Company,CA,USA).Loss in DiOC6staining indicates an association of the disruption of mitochondrial inner transmembrane potential(Δψm).Cytochrome c(cyt-c)release analysisThe release of cytochrome c was detected with HPLC and ultraviolet(UV)detector.After induction treatment,cells were treated as reported(Appaix et al.,2000;Elliott et al.,2003).Cells (2×106)were rinsed three times with PBS,scraped from the dish and then lysed and centrifuged cells for separation of mito-chondrion(4°C,25,000g,30min).The positive control was that of cells treated with GA-T and the negative control used intact cells without any treatment.Initial spectroscopic measurements were made on a UNICO spectrophotometer(UNICO,Shanghai, China).Chromatography of cytochrome c was performed using a5μm C18reverse-phase column(250×4.6mm)by Shimadzu HPLC system with UV detector(Shimadzu,Japan).The detec-tion wavelength was393nm.A gradient from20%to60%of acetonitrile in water with trifluoroacetic acid(0.1%v/v)over 20min with a flow rate of1.0ml/min was used.Western blotting analysisAfter GA-T treatment,cells were washed and lysed in lysis buffer(1%NP40,20mM Tris(base pH7.4),137mM NaCl,10% glycerol,and1mM phenylmethyl sulfonyl fluoride).Cell lysates cleared of debris and nuclei were resolved on15%SDS gels and transferred to a polyvinylidene difluoride membrane(LOT 1673B22,Solon,OH,USA).After being probed with specific primary antibodies,including incubation with anti-p53,anti-Bax, anti-Bcl-2and anti-actin,the specific protein complex formed on appropriate secondary antibody treatment(1:1000)was identified using the DAB substrate reagent(Pierce,USA).Total cellular protein was determined using the Bradford method.Analysis of caspases activitiesActivity of caspase-8was measured by using caspase colo-rimetric assay kit(Catalog PT3356-1,BD Biosciences,USA). Briefly,cell lysates were mixed with DTT(10mM)-rich reac-tion buffer containing50mM IETD-pNA,caspase-8substrates, and incubated for1h at37°C.Enzyme-catalyzed release of pNA was monitored using a microplate reader at405nm.The activity of caspase-3was detected by luminometer with cas-pase-Glo3assay kit(Catalog G8090,Promega,USA)according to the manufacturer's protocol.As caspase-3and8was assayed by using respective specific substrate Ac-DEVD-pNA and Ac-IETD-pNA,the cross-reaction activity was avoided.Animal experimentsFour-week old male BALB/c mice were purchased from SLAC Laboratory Animal Co.Ltd.(Shanghai,China).Specific-pathogen-free(SPF)status was verified by the supplier.Mice were maintained in isolation rooms in filter top cages.The light cycle in the rooms was12h daily,the room temperature was at 22±1.1°C and the room humidity was in the range of40–70%. All mice were fed autoclaved mouse feed and autoclaved water.The animals were implanted with1×108cells/ml of95-D in 0.1ml at two flanks per mouse.Tumor growth was examined twice a week after implantation.The solid tumors were collected after being allowed to develop for3weeks and cut as cube of 0.1×0.1×0.1cm,and then implanted into other mice at two flanks per mouse.The xenograft tumor-bearing nude mice were divided randomly into4groups,and each group includes6mice.When the size of solid tumor in tumor-bearing nude mice reached100mm3,the tumor-bearing nude mice were treated with GA-T via celiac injection at the dosage of0,12.5and 25mg/kg for12days,and then observed for another conse-cutive8days.The control group was treated with vehicle mixture only.At the end of the experiments,animals were euthanized with carbon dioxide inhalation,followed by cervical dislocation,and then the solid tumors were picked up.Data were statistically analyzed by solid tumor weight.The rate of inhibition(IR)was calculated according to the formula:IR=[(mean tumor weight of the experimental group−mean tumor weight of the control group)/mean tumor weight of the control group]×100%.Statistical analysisAll experiments were done at least three different times(n=3) unless otherwise indicated.Data are expressed as means±S.D., and significance was assessed by t test.Differences with P b0.05 (⁎),P b0.01(⁎⁎),P b0.001(⁎⁎⁎)were considered significantly different.ResultsGA-T inhibits proliferation of various cancer cells and affects the viability of metastatic lung carcinoma cells by inducing apoptosis and cell cycle arrestWe first investigated the effect of GA-T on proliferation of human cancer cells and normal cells.The results in Fig.2indicate that GA-T caused a decrease in proliferation of some cancer cells. It had higher cytotoxicity to95-D cell line than to normal cell lines.But the effects of GA-T on SMMC-7721and HLF are similar.This indicates that GA-T had different cytotoxic potency207W.Tang et al./Life Sciences80(2006)205–211against different tumor cells,which is also generally observed for other drugs.As shown in Fig.3A,the viability of 95-D cells was suppressed 70%at 50μg/ml at 24h by GA-T.The growth inhibition was exerted in a dose-dependent manner within the indicated concentrations.Its IC 50was estimated to be 27.9μg/ml.At the same time,GA-Tat a low concentration could also strongly inhibit the formation of cell colony of 95-D (Fig.3B).The inhibitory effect also behaved in a dose-dependent manner,and the EC 50was about 3.34μg/ml.To examine whether the decrease of viable tumor cells was caused by induced apoptosis,95-D cells were treated with GA-T and then were analyzed for annexin V-FITC binding.The experimental results are shown in Fig.4.The proportion of cells reactive with the annexin V-FITC conjugate indicated that target cells started to enter apoptosis after treatment.The number of apoptotic cells was about 50%at the concentration of 50μg/ml at 8h.This means that GA-T induced the apoptosis of tumor cells.At the same time,the cell cycle arrest at G 1phase was observed under the treatment of GA-T (Fig.5).Compared withcontrol,the percentage of cells in G 1phase increased from 48%to 76%(at 24h)with an addition of 50μg/ml of GA-T,whereas the percentage of cells in S phase decreased to 13%from 37%at the same condition.GA-T influences the integrity of mitochondria by decreasing the mitochondrial transmembrane potential (Δψm )The disruption of mitochondrial integrity is one of the early events leading to apoptosis.To assess whether the GA-T affects the function of mitochondria,potential changes in mitochon-drial membrane were analyzed by employing amitochondriaFig.2.Growth inhibition effects of GA-T on various cell lines.Viable cell number was detected using MTT reduction.Values are means±S.D.from triplicate cultures,and the experiments were repeated for five times with similarresults.Fig.3.Growth inhibition effects of GA-T against a highly metastatic lung cancer cell line (95-D).(A),cytotoxicity.After GA-T treatment at 0,10,25and 50μg/ml,viable cell number was detected by MTT reduction.(B),colony formation.After GA-T treatment at 0,2,5,10mg/ml,cells were fixed and stained with crystal violet and counted.Values are means±S.D.from triplicate cultures,and the experiments were repeated for five times with similarresults.Fig.4.GA-T induced apoptosis in 95-D cells.The cells were treated at the indicated time at 50μg/ml of GA-T and apoptosis was assayed by annexin V-FITC binding with flow cytofluorometry.Top right quadrant ,dead cells in late stage of apoptosis;Bottom right quadrant ,cells undergoing apoptosis;Bottom left quadrant ,viable cells.(A),0h;(B),4h;(C),8h.Shown are typical data from one of three independent experiments with similar results.For the apoptosis percentage,it takes the total percentage of viable cells,cells undergoing apoptosis,apoptotic cells and necrosis cells as100%.Fig.5.Cell cycle progression was blocked under GA-T treatment in 95-D cells at the indicated time at 50μg/ml.Symbols:blank bar,G 0–G 1phase;dark bar,S phase;gray bar,G 2/M phase.After GA-T treatment,cells were stained with PI and analyzed with flow cytometry.The results are the average of triplicates.For the percentage of cell cycle distribution,it takes the total percentage of cells at G 1–G 0phase,S phase,and G 2/M phase as 100%.208W.Tang et al./Life Sciences 80(2006)205–211fluorescent dye,DiOC 6.As shown in Fig.6,a drop in the mitochondrial membrane potential was observed.The data show that changes in the membrane potential were induced in treated 95-D cells during 4and 8h treatments.A significant decrease of Δψm was detected in cells treated with 50μg/ml GA-T for 4and pared to control,the decrease in the mean fluorescence density was about 10%and 16.7%,respectively.The results illuminate that GA-T could induce Δψm dissipation in a time-dependent manner.A drop in the mitochondrial membrane potential is usually accompanied by release of cyt -c into the cytosol.As shown in Fig.7,cyt-c levels in the cytosol of GA-T treated cells showed a rapid increase.A one-fold increase was seen within 4h.At 8h,about 3-fold increase in the cyt-c level was observed.The data indicate that GA-T increased the release of cyt -c to cytosol in treated tumor cells.GA-T induces activation of caspase-3but not caspase-8In general,induced apoptosis is often associated with activity of a series of caspases,such as caspase-3and caspase-8.In this work,the activity of caspase-3was detected in 95-D cells treated by GA-T.The data are shown in Fig.8A.GA-T noticeably stimulated the activity of caspase-3in tumor cells in a dose-dependent manner.The activity of caspase-3increases 2-and 3-fold respectively at 4and 8h under the drug concentration of50μg/ml compared with the control.In contrast,the activation of caspase-8was not detected during the 4h and 8h incubations (Fig.8B).To identify which caspases are functionally important for GA-T induced apoptosis,selective caspase inhibitors were used in our investigation.As shown in Fig.8C,the caspase-3inhibitor or pan-caspase inhibitor alone but not caspase-8inhibitor can reduce the apoptosis mediated by GA-T.GA-T modulates the p53and Bax expression,but does not affect bcl-2protein expressionThe expression of proteins including p53,Bcl-2and Bax may be involved in an intrinsic apoptosis pathway.In our case,under GA-T treatment,the expression of p53and Bax was found up-regulated in a time-dependent manner,whereas the expression of Bcl-2was not changed (Fig.9).GA-T inhibits the growth of solid tumor implanted in athymic miceWhen solid tumors in athymic mice were treated with the GA-T,the suppression of tumor growth was observed.Fig.10Fig.6.GA-T influences the mitochondrial membrane potential.The cells were treated at the indicated time at 50μg/ml of GA-T.Cells were analyzed as described in “Materials and methods ”.The results are the average of triplicates.Samples without drug treatment were taken ascontrol.Fig.7.Release of cytochrome c from mitochondria after GA-T treatment at the indicated time at 50μg/ml.Cells were analyzed as described in “Materials and methods ”.The results are the average oftriplicates.Fig.8.Effect of GA-T on activities of caspases.The cells were treated at the indicated time at 50μg/ml of GA-T.(A),caspase-3,which activity was detected by luminometer.(B),caspase-8,which activity was monitored using a microplate reader at 405nm.(C),percentage of apoptosis was quantified by annexin-V staining in the presence or absence (CK,control)of selected caspase-8and -3inhibitors.Results are the average of triplicates from one of the three independent experiments.209W.Tang et al./Life Sciences 80(2006)205–211shows the inhibition ratio of tumor growth for the GA-T treatment in nude mice.The results demonstrated that GA-T could suppress tumor growth in vivo.DiscussionIn this work,the treatment of a tumor cell line (95-D cells)with GA-T resulted in the inhibition of the cell growth in a dose-dependent manner.Our further experiments revealed that apoptosis induction and cell cycle progression block were simultaneously responsible for the inhibition of the tumor cell growth.The percentage of cells in G 1cell cycle phase was increased in 95-D cells under the GA-T treatment.For the effect of ganoderma extracts,the cell cycle blocked at the transition from G 1to S phase (Zhu et al.,2000)and G 2/M phase (Lin et al.,2003)were observed .The different effect may be caused by the variety of triterpenes in extracts,because the activities of triterpenes are dependent on their structures (Gan et al.,1998).Caspase cascade plays a key role in apoptosis procedure (Oubrahim et al.,2001).Caspase-3typically functions at the downstream of other caspases and directly activates enzymes that are responsible for DNA fragmentation in intrinsic apoptosis pathway.Caspase-8is considered as a signaling and key caspase in extrinsic pathway.Our data suggest that activation of caspase-3but not caspase-8was involved in the tumor cells'apoptosis induced by GA-T.The use of caspase inhibitors proved that caspase-3was associated with the induced apoptosis.Consistent with this conclusion is the finding that caspase-8inhibitor had no additive effect in preventing GA-T-mediated apoptosis.At the same time,stress-mediated apoptosis is often triggered by mitochondrial function loss and subsequent cyt-c release from mitochondria to cytosol.The role of mitochondria in GA-T-mediated apoptosis was also explored in this work.GA-T induced a loss of mitochondrial potential and the release of cyt-c to cytosol.Taken together,these results indicate that the apoptosis induced by GA-T was through intrinsic pathway related to mitochondrial dysfunction.In induced apoptosis,interactions between Bax and Bcl-2proteins on mitochondria have been postulated to associate with apoptotic pathways (Zong et al.,2003).Many chemotherapeutic drugs activate apoptosis as a function of their anticancer activity.Bcl-2and Bax have also been implicated as major players in the control of apoptosis pathway.Bcl-2and Bcl-xLpromote cell survival,whereas Bax promotes cell death (Yashita et al.,1994).It was suggested that the ratio of Bcl-2to Bax determines survival or death following apoptotic stimulus.Triterpene extract was found to modulate the expression of Bcl-2and Bax in some tumor cell lines (Choudhuri et al.,2002).In this work,the increase of Bax expression was observed whereas the expression of Bcl-2was not changed.This result was consistent with the reported data (Sang et al.,2001).The work suggests that the apoptosis under the GA-T treatment was by regulating the ratio of Bax/Bcl-2groups.The conclusion was similar to the effect of other triterpenes such as asiatic acid (Park et al.,2005)on tumor cells but it has not been known what effects ganoderma triterpenes have on tumor cell lines until now.In many cases,the p53protein has been identified as the effector of apoptosis signals (Levin,1997).It is a regulator of cell cycle progression and mediator of apoptosis in various cases.The key role of p53in the G 1/S checkpoint was its response to DNA damage.Now,there is some evidence that ganoderic acids can inhibit the topoisomerases and damage cellular DNA in our research (data not shown)and other work (Li et al.,2005).In this study,the expression of p53was up-regulated.This means that the biochemical events induced by GA-T were possibly associated with p53protein.Activation of p53may be stimulated by DNA damage under GA-T treatment,and activated p53might either trigger the onset of cell cycle arrest or induce the apoptosis in 95-D cells.On the other hand,we admit that this drug may not work in tumors with p53mutation.At this stage,the acting mechanism of GA-T against other tumor cell lines is not clear,and whether GA-T has another anti-cancer acting target or not is also unknown to us,and will require furtherstudies.Fig.10.The inhibition ratio of solid tumors in athymic mice byGA-T.Fig.11.Proposed pathway involved in apoptosis induced byGA-T.Fig.9.Time-dependent expression of apoptosis regulating proteins under GA-T treatment as observed.(A),p53;(B),Bcl-2;(C),Bax.Following 4h and 8h exposure to 50μg/ml GA-T,the total cellular protein was extracted,resolved using SDS-PAGE,and western blotting analysis was done with indicated antibodies.Data represent means from two independent experiments.210W.Tang et al./Life Sciences 80(2006)205–211Taken together,based on the results obtained above and the current paradigms of apoptosis reported in the literature,a molecular pathway of apoptosis induced by GA-T was proposed as in Fig.11.As it is not yet completely verified,further work can be done to investigate related interesting issues such as the confirmation of apoptosis blockage by blocking p53or Bax induction.This work also suggests that GA-T may be a natural potential apoptosis-inducing agent for highly metastatic lung tumor and it may be also applied to treat other tumor cell lines. Further investigation is on the way in our lab. AcknowledgmentFinancial support from the National Natural Science Foundation of China(#20225619)is gratefully acknowledged. ReferencesAppaix,F.,Minatchy,M.N.,Riva,L.C.,Olivares,J.,Antonsson,B.,Saks,V.A., 2000.Rapid spectrophotometric method for quantization of cytochrome c release from isolated mitochondria or permeabilized cells revisited.Biochimica et Biophysica Acta1457,175–181.Cheung,W.M.,Hui,W.S.,Chu,P.W.,Chiu,S.W.,Ip,N.Y.,2000.Ganoderma extract activates MAP kinases and induces the neuronal differentiation of rat pheochromocytoma PC12cells.FEBS Letters486,291–296. Choudhuri,T.,Pal,S.,Agwarwal,M.L.,Das,T.,Sa,G.,2002.Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction.FEBS Letters512,334–340.Elliott,D.,Crouser,M.E.,Gadd,M.W.,Julian,J.E.,Huff,K.M.,Robbins,K.A., Douglas,R.P.,2003.Quantitation of cytochrome c release from rat liver mitochondria.Annual Review of Biochemistry317,67–75.Gan,K.H.,Fann,Y.F.,Hsu,S.H.,Kuo,K.W.,Lin,C.N.,1998.Mediation of the cytotoxicity of lanostanoids and steroids of Ganoderma tsugae through apoptosis and cell cycle.Journal of Natural Products61,485–487. Gao,Y.H.,Zhou,S.F.,2003.Cancer prevention and treatment by Ganoderma,a mushroom with medicinal properties.Food Review International19,275–325. Ha,T.B.,Gerhauser, C.,Zhang,W.D.,Ho,N.,Fouraste,I.,2000.New lanostanoids from Ganoderma lucidum that induce NAD(P)H:quinone oxidoreductase in cultured hepalcic7murine hepatoma cells.Planta Medica 66,681–684.Jiang,J.,Slivova,V.,Valachovicova,T.,Harvey,K.,Sliva,D.,2004.Gano-derma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3.International Journal of Oncology24, 1093–1099.Levin,X.,1997.p53,the cellular gatekeeper for growth and division.Cell88, 323–331.Li,C.H.,Chen,P.Y.,Chang,U.M.,Kan,L.S.,Fang,W.H.,Tsai,K.S.,Lin,S.B., 2005.Ganoderic acid X,a lanostanoid triterpene,inhibits topoisomerases and induces apoptosis of cancer cells.Life Sciences77,252–265.Lin,S.B.,Li,C.H.,Lee,S.S.,Kan,L.S.,2003.Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C,activating mitogen-activated protein kinases and G2-phase cell cycle arrest.Life Sciences72,2381–2390.Liu,X.,Yuan,J.P.,Chung,C.K.,Chen,X.J.,2002.Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum.Cancer Letters182,155–161.Lu,Q.Y.,Jin,Y.S.,Zhang,Q.F.,Zhang,Z.F.,Heber,D.,Go,V.L.,Li,F.P.,Rao, J.Y.,2004.Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro.Cancer Letters216,9–20. Oubrahim,H.,Stadtman,E.R.,Chock,P.B.,2001.Mitochondria play no roles in Mn(II)-induced apoptosis in HeLa cells.Proceedings of the National Academy of Sciences of the United States of America98,9505–9510. Park,B.C.,Bosire,K.O.,Lee,E.S.,Lee,Y.S.,Kim,J.A.,tic acid induces apoptosis in SK-MEL-2human melanoma cells.Cancer Letters218, 81–90.Sang,S.M.,Pan,M.,Cheng,X.,Bai,N.,Stark,R.,Rosen,R.T.,Lin-Shiau,S.Y., Lin,J.K.,Ho,C.T.,2001.Chemical studies on antioxidant mechanism of garcinol:analysis of radical reaction products of garcinol and their antitumor activities.Tetrahedron57,9931–9938.Sliva,D.,2003.Ganoderma lucidum(Reishi)in cancer treatment.Integrative Cancer Therapies2,358–364.Sliva,D.,2004.Cellular and physiological effects of Ganoderma lucidum (Reishi).Mini-Reviews in Medical Chemistry4,873–879.Tang W.,2006.Purification and antitumor activity of ganoderic acids from Ganoderma lucidum.Ph.D.Dissertation,East China University of Science and Technology.Shanghai,China.Yashita,T.,Krajewski,S.,Krajewski,M.,Wang,H.G.,Lin,H.K.,Liebermann,D.A.,Hoffman,B.,Reed,J.C.,1994.Tumor suppressor p53is a regulator ofBcl-2and Bax gene expression in vitro and in vivo.Oncogene9,799–805. Zhong,J.J.,Tang,Y.J.,2004.Submerged cultivation of medicinal mushrooms for production of valuable bioactive metabolites.Advances in Biochemical Engineering,Biotechnology87,25–59.Zhu,H.S.,Yang,X.L.,Wang,L.B.,Zhao,D.X.,Chen,L.,2000.Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on HeLa cells.Cell Biology and Toxicology16,201–206.Zong,W.X.,Li, C.,Hatzivassiliou,G.,Lindsten,T.,Yu,Q.C.,Yuan,J., Thompson,C.B.,2003.Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis.Journal of Cell Biology162,59–69.211W.Tang et al./Life Sciences80(2006)205–211。
Ganoderma lucidum and its pharmaceutically active compounds Bojana Boh1,Marin Berovic2,Ã,Jingsong Zhang3and Lin Zhi-Bin41Faculty of Natural Sciences and Engineering,University of Ljubljana,Vegova4,1000 Ljubljana,Slovenia2Department of Chemical and Biochemical Engineering,Faculty of Chemistry and Chemical Technology,University of Ljubljana,Askerceva5,1001Ljubljana,Slovenia3Institute of Edible Fungi,Shanghai Academy of Agriculture Sciences,Shanghai,P.R.China 4Department of Pharmacology,Peking University Health Science Center,Beijing10083,P.R.China Abstract.Ganoderma lucidum is a wood-degrading basidiomycete with numerous pharmaco-logical effects.Since the mushroom is very rare in nature,artificial cultivation of fruiting bodies has been known on wood logs and on sawdust in plastic bags or bottles.Biotech-nological cultivation of G.lucidum mycelia in bioreactors has also been established,both on solid substrates and in liquid media by submerged cultivation of fungal biomass.The most important pharmacologically active constituents of G.lucidum are triterpenoids and poly-saccharides.Triterpenoids have been reported to posses hepatoprotective,anti-hypertensive, hypocholesterolemic and anti-histaminic effects,anti-tumor and anti-engiogenic activity, effects on platelet aggregation and complement inhibition.Polysaccharides,especially b-D-glucans,have been known to possess anti-tumor effects through immunomodulation and anti-angiogenesis.In addition,polysaccharides have a protective effect against free radicals and reduce cell damage caused by mutagens.Keywords:Ganoderma lucidum,cultivation,wood logs,sawdust,solid-state cultivation, submerged cultivation,triterpenoids,polysaccharides,b-D-glucans,pharmacological effects, anti-cancer effects,immunomodulation.IntroductionGanoderma is a white rot wood-degrading basidiomycete with hard fruiting bodies.G.lucidum(W.Curt.:Fr.)Lloyd and Ganoderma applanatum(Pers.) Pat.(Aphyllophoromycetideae)are two species most often reported as a source of medicinal compounds.In Asian traditional medicine,the fruiting body of G.lucidum(Fig.1),called Ling-Zhi in Chinese and Reishi in Japanese language,has been used for treatment of several diseases for thousands of years,as reported in Shen Nong’s Materia Medica[1,2].However,an in-creasing systematic research(Fig.2)into the Ganoderma active compounds elucidates its numerous pharmacological effects,such as antitumor,immuno-modulatory,cardiovascular,respiratory,antihepatotoxic and central nervous system effects.Modern uses of Ganoderma therefore include treatment of coronary heart diseases,arteriosclerosis,hepatitis,arthritis,nephritis,bron-chitis,asthma,hypertension,cancer and gastric ulcer[1,3].Publications also report on Ganoderma antiallergenic constituents[4],immunomodulatoryBIOTECHNOLOGY ANNUAL REVIEW VOLUME13ISSN1387-2656DOI:10.1016/S1387-2656(07)13010-6r2007ELSEVIER B.V. ALL RIGHTS RESERVEDÃCorresponding author:Tel:386-1-2419510.Fax:386-1-4760-300.E-mail:marin.berovic@fkkt.uni-lj.si(M.Berovic).265Fig.1.Fruiting body of Ganoderma lucidum (MZKI G97)originally isolated from the Slovenian forest.N u m b e r o f d o c u m e n t s Year Fig.2.Number of new documents on Ganoderma in the Chemical Abstracts Plus database.An increasing growth of publications indicates an accelerated research in Ganoderma mushrooms.The larger proportion of patents vs.non-patent publica-tions during the last years suggests that a shift happened from basic to more applied research and development of new cultivation technologies,pharmaceutical products and nutriceutical formulations.266267 action[5,6],antitumor activity[7],cardiovascular effects[8],liver protection and detoxification,and effects on nervous system[9].New reports emphasize its potential in treatment of viral,especially HIV infections[10–15].G.lucidum is very scarce in nature.As the demands of international mar-kets for G.lucidum fruiting bodies and/or mycelium biomass are in constant increase,an artificial cultivation has become essential.Successful farming on wood logs and in bagsfilled with wood or straw substrates has been known for decades,especially in China.Biotechnological cultivation in bioreactors on solid substrates,or with submerged liquid substrate cultivation has been developed and introduced for small and pilot-plant production[16–20]. The quality and content of physiologically active substances vary from strain to strain,and also depend on location,culture conditions[21],the growth stage of the fungus[22],the processing procedures,and formulation prep-aration[23].Diverse groups of chemical compounds with pharmacological activity have been isolated from the mycelium and fruiting body of Ganoderma species: triterpenoids,polysaccharides,proteins,amino acids,nucleosides,alkaloids, steroids,lactones,fatty acids and enzymes[1,3].The most important pharmacologically active constituents of Ganoderma mushrooms are triter-penoids and polysaccharides.G.lucidum cultivation methodsAs G.lucidum is very scarce in nature,artificial cultivation has become es-sential to meet the demands of international markets(Fig.3).The main traditional G.lucidum fruiting body cultivation methods remain sawdust cultivation in bags or bottles and cultivation on natural logs.Both cultivation technologies depend on the same essential environmental factors, including temperature,humidity and oxygen[24].During the spawn run, mycelia grow at10–381C,with the optimum mycelial incubation temperature between251C and321C.The optimum moisture content of sawdust substrate is65–70%and that of log is around40%.pH4.2–5.3is regarded as op-timum.The mycelial growth does not necessarily need light.Oxygen is in-dispensable to mycelial growth since G.lucidum is a strict aerobe.In the next cultivation stage of primordia formation,G.lucidum fruits and develops at 20–341C,with the optimum temperature27–321C.The humidity of the growing room should be maintained at about90%during primordial in-duction,70–80%during cap formation and30–40%during thefinal stage of fruit body development.Light(50–450lux)is required during primordial formation and fruit body development.After the cap is formed,the growing room has to be well ventilated.Chen[25]published detailed information on substrate formulation for G.lucidum.As G.lucidum is a lignin-degrading white-rot fungus on hardwoods,woody tissue,such as sawdust,is a natural substrate.Thiamincontained in fresh,unprocessed coarse bran is required for mushroom for-mation.A low content of sugar (1%sucrose)triggers formation and acti-vation of lignin-decomposing enzymes.Calcium appears to encourage mushroom differentiation.Water-logging in substrate prevents air exchange and cuts off oxygen supply.If the sawdust particle size is too fine,proper air exchange is impeded.On the other hand,rough wood chips in substrate may puncture the bag and invite contamination.Cultivation of fruit bodies on natural wood logsCultivation on long unsterilized logsIn the past,natural logs as long as one meter were used without sterilization in growing Ganoderma species in China.Fruiting body cultivation on long wood logs took much labor.Long incubation periods (2–3years)were re-quired to obtain mature fruiting bodies on such substrates [24,26].Cultivation on short sterilized logsSince the late 1980s,new trends have been developed using short logs.Al-most all Ganoderma spp.natural log growers adopted the short-log cultiva-tion in China,Japan,the United States and elsewhere.High yield in a shorter cultivation time enabled quicker turnover of the capital.Short-log cultivationFig.3.Main cultivation methods for the production of G.lucidum fruit bodies and mycelia.268269 takes only4–5months for mycelial incubation,and the fruiting body can becropped in the same year.Detailed procedures on short-log cultivation werepublished elswere[24,26–28].The main cultivation stages of growing G.lucidum on short natural logsenclosed in ventilated synthetic bags during spawn run include[26]:Preparation of wood logs.Most broad-leaf hardwoods can be used,t he standard log size is15cm in diameter,and15–24cm long.Moisturecontent is35–40%.Enclosing logs into bags,sterilization.Heat-sealed polypropylene or po-lyethylene bags with micro-filter windows are used.Spawning.A variety of spawns,such as pure culture liquid mycelial spawn,grain spawn and sawdust-bran spawn can be ually5–10g of spawn is used for each log.Spawn run is carried out in darkness,and less oxygen is required.Spe-cial attention should be given to ensure proper mycelial colonization inthe ck of oxygen or poor aeration,such as water-logging,resultsin poor mycelial growth and slow growth rate.Primordia initiation.Ganoderma spp.primordia are usually formed 50–60days after spawning.Brief exposure to very little light triggersGanoderma spp.primordia initiation.Oxygen is also conducive to primordia formation.Embedding in soil.Colonized logs are embedded vertically directly in soil after primordia formation,leaving the primordia above the groundlevel.To retain moisture,the soil is covered with chopped straw.Maintaining suitable growth parameters.The most crucial factor during primordia initiation is to have high humidity,preferably90–95%,whilethe most crucial factor during pileus differentiation in fruiting,is in-crease in ventilation to reduce CO2build-up from the drastic increase inrespiration from Ganoderma spp.fruiting.Differentiation of Ganodermaspp.fruiting is highly sensitive to CO2concentration,which determineswhether antler-shaped fruiting bodies(CO240.1%),or fruiting bodieswith a well-formed pileus(CO2o0.1%)will be produced.CO2concen-tration at0.04–0.05%,as close to fresh air as possible(0.03%CO2),should be maintained for production of pileated mushrooms(mush-rooms with caps).Air humidity can be supplied by afine mist(1–2,or3–4times/day).Harvesting mushrooms.From primordia formation to fruiting body for harvest takes approximately25days.Fruiting maturity is indicated by the disappearance of the undifferentiated white growth at the edge of the fruiting body.Cultivation is then continued at reduced air humidity of60–85%for additional7–10days to encourage further growth in pileate thickness andfirmness.Harvest is done by cutting the stipe (stalk);only2cm of the stipe remains with the pileus.270Post-harvest treatment includes immediate drying under the sun or with heat(601C)for2–3days.Improper drying lowers the quality of the product.Cultivation of fruit bodies on sawdust substratesSawdust substrates in sterilizable bags(synthetic log cultivation) According to Royse[29],most cultivation of G.lucidum is on supplemented sawdust contained in heat-resistant polypropylene bottles or bags.Sawdust of hardwoods is usually supplemented with rice bran(10%)and CaCO3 (3%),moistened with water andfilled(700g)into plastic bags.A plastic collar then isfitted onto each bag and closed with a cotton plug.After heat treatment(95–1001C for5h)the substrate is allowed to cool overnight and then inoculated with grain or sawdust spawn.The inoculated substrate is incubated for3–4weeks or until the spawn has fully colonized the substrate. Mushroom production is initiated by maintaining air temperature at about 281C with relative humidity in the range85–90%.Basidiocarps begin to appear in about1–2weeks after initiation.Approximately2–3months after the appearance of primordia,mushrooms are ready to harvest.A mushroom is considered mature when the whitish margin around the edge of the bas-idiocarp has turned red.The substrate may yield another harvest of mush-rooms after removal of thefirstflush.Chen[25]recommended the following substrate formulation for Gano-derma cultivation:oak sawdust80%,fresh unprocessed coarse wheat bran 18%,supplemented with sucrose1%,calcium carbonate(or calcium sul-phate)1%,with approximately67–70%water.For500g dry substrate (containing400g oak sawdust and90g wheat bran),1l of water containing 5g of sucrose and5g of calcium carbonate was ing this formu-lation,scale-up cultivation by mushroom growers in the United States and Canada has been successful.Another extensive article on Ganoderma culti-vation in bags(synthetic logs)is available in[30].Several publications describe G.lucidum cultivation in bags under uncon-ventional conditions.A Japanese patent[31]claimed cultivation of G.lucid-um fruit bodies in an antler form in bags.Nascimento[32]grew G.lucidum on hardwood chips and sawdust of two Chilean native red wood trees,Not-hofagus obliqua and Nothofagus alpine,in polypropylene bags.No difference was observed in the fruiting stage between the two species of tree wood. Gonzalez-Matute et al.[33]studied the sunflower seed hulls as a main nu-trient source for the cultivation of G.lucidum in bags(synthetic log system). The study concluded that sunflower seed hulls could be used as the main energy and nutritional source in substrates for G.lucidum cultivation,and the addition of5%malt to the substrate improved the mushroom growth rate.271 Yang et al.[34]utilized stillage grain from a rice-spirit distillery in the cul-tivation of G.lucidum in polypropylene bags.Due to its high content of carbohydrate and nitrogen,stillage grain was considered as a nutritive substrate for mycelial growth.Sawdust supple-mented with stillage grain at a ratio4:1at a water content of60%was optimal for the production of fruiting body.Hsieh et al.[35]used the soy residue from the waste of tofu manufacturing to culture G.lucidum in po-lypropylene plastic bags.The fruiting bodies were fully developed only for the C/N ratios of70and80.Sawdust substrates in bottles and potsKim[36]grew twenty-one isolates of nine Ganoderma species(including G.lucidum)in2l sterilizable plastic bottles on solid substrates based on sawdust.The substrate was prepared by mixing oak sawdust and wheat bran (8:2,v/v),and the water was added to65%of the total volume.The culti-vation room was maintained at28–311C and85%of relative humidity until primordial formation and ventilated once or twice for10–20min afterwards. After the pileus was formed,ventilations were frequent(5–6times/day)and the relative humidity was controlled at80–85%.A Japanese patent[37]claimed an arrangement for cultivating G.lucidum or other mushrooms in bottle containers,where a negative voltage was ap-plied to the container body for activation and production of mushrooms of excellent quality in a short period.Another Japanese patent described a cultivation method for Ganoderma in pots by protecting a nursery bed against the infiltration of bacteria by a plastic cover.In a work by Shigeru [39],finely crushed thinned citrus fruits and residue of citrus fruit juice were utilized in the culture medium,mixed with rice bran at a weight ratio of about10:2for G.lucidum in bottles.Ganoderma was cultured at about 25–301C and about60–90%humidity to develop fruit bodies.Sawdust substrates in trays or bedsChen[28]reported on G.lucidum cultivation on trays or beds in North America.The article stated that wood-chip or sawdust beds were labor sav-ing,if contamination was avoided.The substrate,12cm deep,composed of wood chips supplemented with sawdust,was spread evenly over cultivation trays or beds.Colonized sawdust,grain,or liquid spawn,0.5cm thick or more,was seeded on the surface under still air and covered with a plastic sheet.After3–5days,a layer of white mycelia became visible and begun to penetrate the substrate.When primordia were formed after1–2months,the plastic cover sheet was removed.The growing space was maintained at one-third diffuse light,85–95%relative humidity and251C.Air circulation or aeration was provided3–5times/day5–10min each time.272Cultivation of G.lucidum mycelia in a bioreactorSolid-state cultivationA Slovenian patent[40]claimed a process of growing G.lucidum on a solid cultivation substrate using the solid-state cultivation in a horizontal stirred bioreactor.Beech sawdust was used as a solid cultivation substrate.The process enabled a precise leading and monitoring of the fungal growth at sterile rge quantities of biomass could be prepared according to the process to yield products applicable to pharmacy.The biomass could also be used as a solid inoculum for the further cultivation of G.lucidum.A World patent application with a Chinese priority[41]described a method for propagating fungi and producing fungal metabolites with me-dicinal activities,using a solid-state fermentation process and cultivation in bottles.The invention also described substrates for small-and large-scale fungal cultivation of G.lucidum,Cordyceps sinensis,Antrodia camphorata, Trametes versicolor and Agaricus blazei.Chen[28]reported that in North America,Ganoderma mycelial prepara-tions for human consumption are produced by solid-state fermentation on grain-or soy-based substrates.Submerged cultivation in liquid mediaAuthors use different substrate compositions for the submerged cultivation of G.lucidum mycelia.An example given in[28]consisted of sucrose50.0g, ammonium succinate3.2g,KH2PO41.0g,MgSO4Á7H2O0.3g,FeSO4Á7H2O 13.0mg,ZnSO4Á7H2O 4.0mg,yeast or malt extract10.0g,adjusted to pH5.2with concentrated ammonia,water to1l.An optimized medium for a shake-flask submerged culture of G.lucidum, reported by Chang et al.[42]consisted of1.88g/l CaCO3,71.4brown sugar, 12.1g/l malt extract, 2.28g/l yeast extract,18.4g/l skim milk, 3.44g/l safflower seed oil,3.96g/l olive oil,at pared to an unoptimized substrate,the mycelium formation was markedly improved from1.70g/l to 18.70g/l,and the polysaccharide production increased from0.140g/l to 0.420g/l.Hsieh et al.[43]studied production of polysaccharides by G.lucidum in shakeflasks under various limitations of nutrients,including carbon-source, nitrogen-source,phosphate-source,magnesium-source and dissolved oxygen. Different responses of polysaccharide production were observed under different limitations of nutrients.A Slovenian patent[44]described a procedure for G.lucidum inoculum preparation in a shaked culture,and the production of mycelia by submged fermentation in a bioreactor.According to the patent description,potato dextrose agar of the total area of100–200mm2overgrown by the fungus273 G.lucidum was transferred into a500ml Erlenmayerflask containing100ml of substrate.The vegetative substrate contained thefiltrate of300g/l of peeled cooked potato,20g/l of glucose and2%v/v of olive oil,and wasfilled with distilled water of pH5.8to the total volume of1l.The culture was shaken in this medium for80–160h at the temperature of20–301C at80–160 rotations per minute.In a bioreactor,the substrate was sterilized at the temperature of110–1301C and with mixing200–400rotations per minute,for about half an hour.After cooling down to301C,the sterile substrate in a bioreactor was inoculated with17%v/v of the vegetative inoculum contain-ing mycelium of G.lucidum,produced in a shaken culture of the age of 120–170h.The growth of the mycelium lasted for160h during which the concentration of dissolved oxygen was maintained by aeration of6–15l/min at200–600rotations/min,maximal redox potential during growing amount-ing to410–460mV and minimal partial oxygen pressure from25to33%v/v at pH from4.10to4.30.Yang and Liau[45]studied the influence of cultivation parameters on polysaccharide formation by G.lucidum in submerged cultures.The substrate consisted of glucose50g/l;K2HPO40.5g/l;KH2PO40.5g/l;MgSO4Á7H20 0.5g/l;yeast extract1g/l;and ammonium chloride4g/l.Optimal temperature was30–351C and the pH4–4.5.Polysaccharide concentration reached 1.6mg/ml.Agitation and aeration influenced the formation and secretion of polysaccharides.The optimal rotating speed was150rpm in7-dayflask cul-tures,while the agitation speed employed in fermenter culture greatly affected the production rate and maximum concentration of polysaccharide. Although higher speeds enhanced mixing efficiency and polysaccharide re-lease,higher shear stress had a detrimental effect on mycelial growth and polysaccharide formation.Lee[46]reported that pH control substantially affected mycelial cell growth and exopolysaccharide production of the mycelial cultivation of G.lucidum.The fermentor was a concentric draught-tube internal loop type which can greatly reduce shear stress as compared to an impeller-type fermentor.Five percent(v/v)of the culture was inoculated into the fermentor and cultivated at251C with air being supplied at a rate of2.5vvm under batch pared to the uncontrolled pH cultivation,the bistage pH control technique,in which pH was shifted from3to6at the initial phase of the exponential growth,increased exopolysaccharide production from4.1g/l to20.1g/l,retained the desirable morphologies of the mycelia during cultivation,and resulted in low viscosity and yield stress of the culture broth.Fang and Zhong[47]investigated the effects of initial pH on simultaneous production of ganoderic acid and a polysaccharide by G.lucidum.An initial pH value,varying within the range3.5–7.0,had a significant effect on the cell growth and product biosynthesis.At an initial pH of6.5,a maximum in biomass of17.370.12g/l by dry weight was obtained,as well as a maximal274specific production of ganoderic acid of1.2070.03mg/100mg dry weight and total production of207.972.7mg/l.Lowering the initial pH from6.5to 3.5gradually led to a higher production of extracellular polysaccharide and a higher specific production of intracellular polysaccharide.The same research group[48]studied the effects of nitrogen source and initial glucose concen-tration in submerged fermentation of G.lucidum for simultaneous production of bioactive ganoderic acids and polysaccharides.The cells could not grow well when either yeast extract or peptone was used as the sole nitrogen source.However,a combined addition of5g/l of yeast extract and5g/l of peptone was optimal for the cell growth and metabolite production.Initial glucose concentration within20–65g/l greatly affected the cell growth and product biosynthesis.The highest levels of cell density(16.7g dry weight/l), intracellular polysaccharide(1.19g/l)and ganoderic acid(212.3mg/l)were obtained at an initial glucose concentration of50g/l.Fang et al.[49]also reported on a significance of inoculation density control in production of polysaccharide and ganoderic acid by submerged culture of G.lucidum.Control of inoculation density was significant for cell growth,morphology,and production of polysaccharide and ganoderic acid.A maximal cell concentration of15.7g dry cell weight/l was obtained at an inoculation density of330mg dry weight/l.For inoculation density within the range70–670mg dry weight/l,a large inoculation density led to a small pellet size and high production of extracellular and intracellular polysaccharides, while a relatively big pellet size and high accumulation of ganoderic acid were observed at a low inoculation density.It was also shown that small pellet size resulted in high polysaccharide production,while large pellet size led to high production of ganoderic acid.In a work of Berovic et al.[20]G.lucidum was cultivated in a liquid substrate based on potato dextrose and olive oil.The influences of inoculum and oxygen partial pressure in batch and fed-batch cultivation in a10l lab-oratory-stirred tank reactor were studied.The cultivation conditions were temperature of cultivation,T¼301C;mixing,N¼300minÀ1;aeration, Qg¼10l minÀ1;average values of pH, 5.8–4.2;oxygen partial pressure, 70–80%and redox potential,Eh¼300–400mV.Fungal biomass was found to be oxygen and shear ing a17%(wet weight)6days old veg-etative inoculum,9.6g lÀl of dry biomass in batch cultivation and15.2g lÀl in fed-batch process were obtained.Extracellular(9.6g lÀl)and intracellular (6.3g lÀl)polysaccharide fractions were isolated.Extracellular polysaccharide fraction and four intracellular polysaccharide fractions were obtained.Po-lysaccharides were further separated by ion-exchange,gel and affinity chro-matography.The isolated polysaccharides were mainly b-D-glucans. Immunostimulatory effects of isolates were tested on induction of cytokine (tumor necrosis factor a(TNF-a)and interferon g(IFN-g))synthesis in pri-mary cultures of human peripheral blood mononuclear cells(PBMC)isolated from a buffy coat.The TNF-a-inducing activity was comparable with275 romurtide,which has been used as a supporting therapy in cancer patients treated with radiotherapy and/or chemotherapy.Tang and Zhong[50]studied the effects of carbon source and initial sugar concentration on the production of ganoderic acids and polysaccharided in a fed-batch G.lucidum cultivation process in shakeflasks and in a stirred bioreactor.Sucrose as a carbon source was suitable for the extracellular polysaccharide production although the cells could not grow ctose was beneficial for the cell growth and production of ganoderic acid and intracellular polysaccharides.When the initial lactose concentration exceeded 35g/l,the ganoderic acid accumulation was decreased.The ganoderic acid production was remarkably improved by pulse feeding of lactose,when its residual concentration was between10g/l and5g/l.Submerged fermentation of G.lucidum is viewed as a fast and cost-effective alternative for efficient production of polysaccharides and ganoderic acids from G.lucidum.However,submerged cultivation of mycelia is characterized by an increase in broth viscosity with time,which is a consequence of in-creased cell concentration and the accumulation of extracellular polysaccha-rides that dramatically alter the rheological characteristics of fermentation broth,and create a series of problems that have to be solved,especially oxygen supply.Oxygen affects cell growth,cellular morphology,nutrients uptake and metabolite biosynthesis.Tang et al.[51]reported on the effects of oxygen supply on the submerged cultivation of G.lucidumin in a3.5l agitated bioreactor with two six-bladed turbine impellers.Aeration was through a ring sparger with a pore size of0.8mm.Fermentation was conducted at301C in the dark.The cultivation medium consisted of35g/l lactose,5g/l peptone, 2.5g/l yeast extract,1g/l KH2PO4ÁH2O,0.5g/l MgSO4Á7H2O and0.05g/l Vitamin B1.The results showed that an initial volumetric oxygen transfer coefficient(K L a)value within the range16.4–96.0hÀ1had a significant effect on the cell growth,cellular morphology and metabolites biosynthesis.An increase of initial K L a led to a bigger size of mycelia aggregates and a higher production of ganoderic acids.Fang et al.[49]studied the significance of inoculation density and pellet size in the submerged culture of G.lucidum on production of polysaccharides and ganoderic acids.Inoculum sizes of70,170,330and670mg dry cell weight(DW)/l were tested.Inoculation density significantly affected the cul-tivation process.Small pellet size resulted in high polysaccharide production, while large pellet size led to high production of ganoderic acid.Pellets with diameters smaller than1.2mm,1.2–1.6mm and larger than1.6mm had ganoderic acid content of0.98,1.27and1.62mg/100mg DW,respectively.Some authors reported on submerged cultivation of G.lucidum mycelia on unconventional substrates,including liquid waste materials,such as thin stillage and deproteinated cheese whey.Hsieh et al.[52]produced G.lucidum polysaccharides by reusing thin stillage(from a wine manufacturing plant)in a shakeflask culture.By276adjusting the pH5,a60%thin stillage was used successfully to grow the mycelia of G.lucidum with the highest cell concentration of7.8g/l and po-lysaccharide production of7.50g/l.Molasses addition produced the highest mycelia growth rate and a cell concentration increase to12.7g/l.Glucose addition led to increase overall polysaccharides production up to3.69g/l. Polysaccharides in the range of molecular weight from10,000to200,000Da were also found at almost three times production with thin stillage only.Lee et al.[53,54]utilized deproteinated cheese whey for cultivating mycelia of the G.lucidum in a bioreactor by submerged cultivation and concluded that cultivation of G.lucidum mycelia could offer a potential cost-effective solution for an alternative utilization of the deproteinated cheese whey. Main pharmacologically active compounds in G.lucidumThe most important pharmacologically active constituents of Ganoderma mushrooms are triterpenoids and polysaccharides(Fig.4).Triterpenoids from Ganoderma mushroomsOver150triterpenoids were found in Ganoderma spp.,such as ganoderic (highly oxygenated C30lanostane-type triterpenoids),lucidenic,ganodermic, ganoderenic,ganolucidic and applanoxidic acids,lucidones,ganoderals and ganoderols[5–64].Representative examples are shown in Figs.5–13.Boh et al.[65]reported that the quantity of triterpenoids differed in older and younger parts of G.applanatum fruiting bodies.The highest amount of triterpenoid acids was found in the tubes(6.4mg/g of air-dried weight),fol-lowed by the younger dark context layer of the pileus(2.5mg/g),the older white context layer(0.6mg/g)and the upper surface of the fruiting body (0.6mg/g).Triterpenoids have numerous pharmacological effects,as summarized be-low:Anti-hepatotoxic and hepatoprotective effectsHirotani et al.[55]successfully isolated ganoderic acids R and S from the cultured mycelia and proved their strong anti-hepatotoxic activity in the galactosamine-induced cytotoxic test with primary cultured rat hepatocytes. Kim et al.[66]reported on beta-glucuronidase-inhibitory and hepatoprotec-tive effect of G.lucidum.Anti-tumor effectsIsolated ganoderic acids Z,Y,X,W,V and T from Ganoderma mycelia demonstrated cyctotoxic activitiy in vitro on hepatoma cells[67].。